Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01074
Species: Homo sapiens
Position : chr21:43795658-43798708
Year: 2021
Title: Enhancer release and retargeting activates disease-susceptibility genes.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: breast carcinoma
PMID:  34040254
MONDO: MONDO:0004989
Tissue: breast
Tissue Ontology ID: UBERON:0000310
Cell Source: MCF-7
CVCL ID: CVCL_0031
Cell Type: epithelial cell
Cell Ontology ID: CL:0000066
Experiment Type: Enhancer activity assay; Functional perturbation assay; TF binding assay; Chromatin interaction assay; Endogenous enhancer perturbation
High Throughput Method: GRO-seq; ChIA-PET; ChIP-seq; pooled CRISPRi screen; GWAS
Low Throughput Method: CRISPR/Cas9 enhancer deletion; 4C-seq; qRT-PCR; ChIP-qPCR; CRISPRi; Site-directed/motif mutagenesis
About Target Gene
Target gene : TFF1
About TF
TF name : FOXA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_04617 chr21:43795658-43798708 breast epithelial cell breast cancer
E_04618 chr21:43796920-43797320 breast malignant cell breast cancer
E_04619 chr21:43796920-43797320 breast malignant cell breast cancer
Expression of Target Genes for the Enhancer